Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...

A new study from UCLA Health has uncovered how inflammation in brain blood vessels exacerbates damage in vascular dementia ...

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...

Only four trials measured side effects systematically. We concluded that there are significant gaps in the evidence needed to guide decisions about medicines for sleeping problems in dementia. More ...

Dementia care represents a significant burden to our society. Although we are still far from any cure for dementia, there are several medications available for symptomatic management of Alzheimer ...

Researchers at the Francis Crick Institute and UCL have shown that genetic messages are misplaced in nerve cells in a model ...

In a nutshell People with type 2 diabetes taking semaglutide (Ozempic/Wegovy) showed up to 46% lower dementia risk compared ...

The study, carried out by experts from the University of Nottingham and funded by the National Institute for Health Research ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could ...

These tests can help sort out vascular dementia from other types of dementia and Alzheimer disease. Lumbar puncture (Spinal tap). This is done to analyze cerebrospinal fluid for inflammation, ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...